As Neutra Corp. (OTCBB: NTRR) prepares for the release of its
cutting-edge Diamond Anvil vaporizer pen next month, New York has become
the 23rd state to legalize medical marijuana.
The state senate passed a bill Friday that will authorize cannabis for
therapeutic purposes for patients with serious illnesses such as cancer,
AIDS and epilepsy. New York adds yet another major marketplace for
ancillary businesses such as NTRR to shop their products.
Unlike most other medical marijuana states, New York passed a bill that
does not allow patients to smoke the drug, making advanced tools such as
NTRR's Diamond Anvil vapor pen necessities. Through its wholly owned
subsidiary, Diamond Anvil Designs, the company plans to deliver a
lightweight, portable, smoke-free delivery system that will stand out
from competing products in the marketplace thanks to its customizable
power levels, multi-substance vaporization capacity and best-in-class
NTRR is planning the device's product launch for mid-July. While no
official estimate is available on the potential market for ancillary
products such as vaporizers, horticultural equipment and more, legal
cannabis sals are expected to reach $2.57 billion this year, up from
$1.53 billion a year ago. Chris Walsh, editor of Marijuana
Business Daily, told the LA Times earlier this year that
these ancillary business' "annual revenue is easily in the hundreds of
millions, and likely much more."
By providing a new technology that can be adapted to deliver a variety
of nutraceutical substances, including dry herbs, oils and waxes, Neutra
Corp. plans to enjoy unprecedented growth in 2014 alongside Cannabis
Science, Inc. (OTCBB: CBIS), GW Pharmaceuticals, plc (NASDAQ: GWPH),
INSYS Therapeutics, Inc. (NASDAQ: INSY) and CannaBusiness Group, Inc.
(OTCBB: CBGI), delivering technological advancements in the cultivation
and processing of cannabis in approved markets.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the
development and marketing of natural wellness solutions, including
cannabis-related products. For investing information and performance
data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the Company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of success. This
news release speaks as of the date first set forth above and the Company
assumes no responsibility to update the information included herein for
events occurring after the date hereof.
[ Back To NFVZone's Homepage ]